Company Ticker News September 29, 2021AbbVie Stock Rises After FDA Approves 3rd Headache Drug 0 0 Share
Company Ticker News September 29, 2021AbbVie's (ABBV) Migraine Prevention Drug Qulipta Gets FDA Nod 0 0 Share
Company Ticker News September 29, 2021FDA Gives Nod To First Oral CGRP Receptor To Prevent Migraine From AbbVie 0 0 Share
Press Release September 29, 2021FDA Approves QULIPTA™ (atogepant), the First and Only Oral CGRP Receptor Antagonist Specifically Developed for the Preventive Treatment of Migraine 0 0 Share
